Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Noom operates primarily as a behavioral-change platform that integrates medication options, while Hims functions as a direct-to-consumer telehealth provider offering multiple GLP-1 medications alongside consultations
Kilgore KP, Lee MS, Leavitt JA et al (2017) Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity
We administer each of these medications through injections, but dosing differs between the two
These include semaglutide (Wegovy) and liraglutide (Saxenda), along with newer combination agents like tirzepatide (Zepbound), which targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
US$ 29.27
US$ 22.71
/media/img/mt/2026/06/2026_06_15_GLP_1s/original.jpg){kind=icon}
US$ 23.44
US$ 26.12
US$ 20.38
US$ 22.37
US$ 27.26
